Stryker (SYK) Net Income towards Common Stockholders (2009 - 2026)

Stryker's (SYK) quarterly Net Income towards Common Stockholders came in at $745.0 million in Q1 2026, up 13.91% year-on-year from $654.0 million in Q1 2025, and down 12.25% on a QoQ basis from $849.0 million in Q4 2025.

Stryker (SYK) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

Stryker (SYK) has 18 years of Net Income towards Common Stockholders data on file, last reported at $745.0 million in Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 13.91% year-over-year to $745.0 million in Q1 2026; TTM through Mar 2026 was $3.3 billion, a 16.72% increase from a year earlier, with the FY2025 full-year figure at $3.2 billion, up 8.45% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at $745.0 million, down from $849.0 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for SYK reached as high as $1.1 billion in Q4 2023 and fell as low as $323.0 million in Q1 2022.
  • Historically, Net Income towards Common Stockholders has averaged $735.7 million across 5 years, with a median of $745.0 million in 2026.
  • Across the five-year window, Net Income towards Common Stockholders jumped 103.02% in 2023 and slumped 52.23% in 2024, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at $563.0 million in 2022, then soared by 103.02% to $1.1 billion in 2023, then slumped by 52.23% to $546.0 million in 2024, then surged by 55.49% to $849.0 million in 2025, then slipped by 12.25% to $745.0 million in 2026.
  • Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $745.0 million in Q1 2026, $849.0 million in Q4 2025, and $859.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 182.35 Bn 175.06 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.79 Bn 125.91 Bn 3.81 Bn 745.00 Mn
3 Medtronic 107.93 Bn 98.71 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 67.82 Bn 66.37 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.03 Bn 44.36 Bn 1.29 Bn -
6 Dexcom 28.30 Bn 27.18 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 27.90 Bn 25.62 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 27.01 Bn 26.43 Bn - -
9 Koninklijke Philips 23.96 Bn 20.83 Bn 2.07 Bn 176.78 Mn
10 Steris 21.44 Bn 21.00 Bn 697.10 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 745.00 Mn
Dec 31, 2025 849.00 Mn
Sep 30, 2025 859.00 Mn
Jun 30, 2025 884.00 Mn
Mar 31, 2025 654.00 Mn
Dec 31, 2024 546.00 Mn
Sep 30, 2024 834.00 Mn
Jun 30, 2024 825.00 Mn
Mar 31, 2024 788.00 Mn
Dec 31, 2023 1.14 Bn
Sep 30, 2023 692.00 Mn
Jun 30, 2023 738.00 Mn
Mar 31, 2023 592.00 Mn
Dec 31, 2022 563.00 Mn
Sep 30, 2022 816.00 Mn
Jun 30, 2022 656.00 Mn
Mar 31, 2022 323.00 Mn
Dec 31, 2021 662.00 Mn
Sep 30, 2021 438.00 Mn
Jun 30, 2021 592.00 Mn